APRIL 23, 2014
Pharmatest to attend 2014 OARSI World Congress
Pharmatest will be attending the 2014 OARSI World Congress in Paris, France on April 24-27, 2014.
Pharmatest attends the congress with a scientific presentation that characterizes the effects of intra-articular rhBMP-7 treatment on the development of posttraumatic OA.
Presentation: Intra-articular treatment with recombinant human bone morphogenetic protein 7 (BMP-7) attenuates the development of osteoarthritis in a surgically induced rat model.
If you would like to meet our representative during the meeting, please click here.